Document Detail


Preventive effects of glycyrrhizin on estrogen-related endometrial carcinogenesis in mice.
MedLine Citation:
PMID:  17273742     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We have previously reported on the inhibitory effect of Glycyrrhizae radix (Gl radix) on mouse endometrial carcinogenesis. The present study was performed to clarify the effects of Gl radix and glycyrrhizin (GL), the main part of Gl radix, on estradiol (E2)-related endometrial carcinogenesis. Both Gl radix and GL exerted a significant decrease in the COX-2, IL-1alpha and TNF-alpha mRNA expressions. GL generated a significant decrease in the incidence of endometrial adenocarcinoma. Accordingly, the preventive effects of Gl radix may be attributable to GL, thus being related with the suppression of COX-2, IL-1alpha and TNF-alpha. Gl radix and GL could therefore be a promising formula for the chemoprevention of human endometrial cancer.
Authors:
Kenji Niwa; Zenglin Lian; Kyoko Onogi; Wu Yun; Liulin Tang; Hideki Mori; Teruhiko Tamaya
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Oncology reports     Volume:  17     ISSN:  1021-335X     ISO Abbreviation:  Oncol. Rep.     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-02-02     Completed Date:  2007-05-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9422756     Medline TA:  Oncol Rep     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  617-22     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Gifu University School of Medicine, Gifu 501-1194, Japan. kniwa@gifu-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / therapeutic use*
Cyclooxygenase 1 / drug effects
Cyclooxygenase 2 / drug effects
Endometrial Neoplasms / metabolism,  prevention & control*
Estrogens / metabolism
Female
Glycyrrhiza / chemistry*
Glycyrrhizic Acid / therapeutic use*
Immunohistochemistry
Interleukin-1alpha / metabolism
Mice
Mice, Inbred ICR
Neoplasms, Hormone-Dependent / prevention & control*
Ovariectomy
Plant Extracts / therapeutic use*
RNA, Messenger / drug effects
Reverse Transcriptase Polymerase Chain Reaction
Tumor Necrosis Factor-alpha / drug effects
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Estrogens; 0/Interleukin-1alpha; 0/Plant Extracts; 0/RNA, Messenger; 0/Tumor Necrosis Factor-alpha; 1405-86-3/Glycyrrhizic Acid; EC 1.14.99.1/Cyclooxygenase 1; EC 1.14.99.1/Cyclooxygenase 2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  S-phase reduction in T47D human breast cancer epithelial cells induced by an S100P antisense-retrovi...
Next Document:  Clinical significance of RCAS1 as a biomarker of ovarian cancer.